1.
|
Phase: Phase II, Phase I Type: Treatment Status: Approved-not yet active Age: Over 18 Sponsor: Other Protocol IDs: HCI59004, NCT01728181
|
|
2.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: AV-951-12-205, NCT01673386
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: AV-951-12-204, 2012-003507-35, NCT01745367
|
|
4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NU 12S02, NCI-2012-03188, STU00073826, NCT01782313
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: WINSHIP2302-12, IRB00061422, NCT01807156
|
|
6.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 13-084, NCT01834183
|
|
7.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: I 229112, NCI-2013-00756, NCT01835223
|
|
8.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: I 220412, NCI-2012-03185, P30CA016056, NCT01769885
|